| 1340 Clinicopathologic and Next Generation Sequencing Analysis of Follicular Dendritic Cell Sarcomas T Aladily, S Loghavi, LJ Medeiros, R Miranda | | |
| 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis Z Hu, S Hu, C Ji, Z Tang, B Thakral, S Loghavi, LJ Medeiros, W Wang Leukemia research 65, 25-28, 2018 | 11 | 2018 |
| 86. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation K Nahmod, R Miranda, F Vega, B Thakral, N Pemmaraju, S Loghavi, ... Cancer Genetics 278, 26-27, 2023 | | 2023 |
| A cryptic BCR-PDGFRB fusion resulting in a chronic myeloid neoplasm with monocytosis and eosinophilia: a novel finding with treatment implications SK Gupta, N Jain, G Tang, A Futreal, SA Wang, JD Khoury, RK Yang, ... Journal of the National Comprehensive Cancer Network 18 (10), 1300-1304, 2020 | 4 | 2020 |
| A Descriptive Analysis of TP53 Y220C Mutations in Patients with Hematologic Malignancies G Gener-Ricos, K Sasaki, S Loghavi, A Maiti, N Short, F Haddad, N Daver, ... Blood 140 (Supplement 1), 11830-11832, 2022 | | 2022 |
| A Large Multicenter Series of Post-Transplant Lymphoproliferative Disorders Involving the Gastrointestinal Tract and Liver A Booth, S Loghavi, R Gonzalez, K Mirza, B Cox, G Malvar, LJ Medeiros, ... LABORATORY INVESTIGATION 100 (SUPPL 1), 623-625, 2020 | | 2020 |
| A multimodality work‐up of patients with hypereosinophilia Z Hu, PC Boddu, S Loghavi, RN Miranda, M Goswami, LJ Medeiros, ... American journal of hematology 93 (11), 1337-1346, 2018 | 16 | 2018 |
| A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia K Saxena, SM Herbrich, N Pemmaraju, TM Kadia, CD DiNardo, ... Cancer 127 (20), 3761-3771, 2021 | 46 | 2021 |
| A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and … J Senapati, M Muftuoglu, J Ishizawa, HA Abbas, S Loghavi, G Borthakur, ... Blood cancer journal 13 (1), 101, 2023 | 11 | 2023 |
| A phase Ib/II study of ivosidenib with venetoclax+/-azacitidine in IDH1-mutated hematologic malignancies. CA Lachowiez, JS Garcia, G Borthakur, S Loghavi, Z Zeng, GD Tippett, ... Journal of Clinical Oncology 40 (16_suppl), 7018-7018, 2022 | 21 | 2022 |
| A phase Ib/II study of ivosidenib with venetoclax+/-azacitidine in IDH1-mutated myeloid malignancies. CA Lachowiez, G Borthakur, S Loghavi, Z Zeng, TM Kadia, L Masarova, ... Journal of Clinical Oncology 39 (15_suppl), 7012-7012, 2021 | 29 | 2021 |
| A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies CA Lachowiez, S Loghavi, Z Zeng, T Tanaka, YJ Kim, H Uryu, S Turkalj, ... Blood cancer discovery 4 (4), 276-293, 2023 | 39 | 2023 |
| A Phase II study of azacitidine, venetoclax and trametinib in relapsed/refractory AML harboring a ras pathway-activating mutation SP Desikan, F Ravandi, N Pemmaraju, M Konopleva, S Loghavi, ... Blood 138, 4436, 2021 | 4 | 2021 |
| A phase II study of azacitidine, venetoclax, and trametinib in relapsed or refractory acute myeloid leukemia harboring RAS pathway-activating mutations SP Desikan, F Ravandi, N Pemmaraju, M Konopleva, S Loghavi, ... Acta haematologica 145 (5), 529-536, 2022 | 18 | 2022 |
| A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma KA Lyapichev, S Piña-Oviedo, LJ Medeiros, MG Evans, H Liu, ... Modern Pathology 33 (3), 367-379, 2020 | 42 | 2020 |
| A randomized phase II trial of 5-day versus 10-day schedules of decitabine in older patients with newly diagnosed acute myeloid leukemia NJ Short, HM Kantarjian, S Loghavi, X Huang, W Qiao, G Borthakur, ... The Lancet. Haematology 6 (1), e29, 2019 | 2 | 2019 |
| A rare histologic variant of a common lymphoma S Loghavi, LJ Medeiros Blood, The Journal of the American Society of Hematology 128 (25), 3012-3012, 2016 | | 2016 |
| A Young Man With Anemia and Neutropenia S Loghavi The Hematologist 20 (4), 2023 | | 2023 |
| Aberrant Cytokeratin Expression in Acute Myeloid Leukemia is Associated with Complex Karyotype and TP53 Alterations H Rahman, J Khoury, C Bueso-Ramos, T McDonnell, A Salem, S Wang, ... LABORATORY INVESTIGATION 98, 546-546, 2018 | | 2018 |
| Abnormal myometrial vasculature explains some cases of menorrhagia S Loghavi, EG Silva LABORATORY INVESTIGATION 89, 225A-225A, 2009 | 1 | 2009 |
